http://www.mesotheliomacenter.org/mesothelioma-news Just another WordPress weblog Tue, 01 Jul 2008 14:59:12 +0000 http://backend.userland.com/rss092 en The Mesothelioma Center[note] within the Herbert Irving Comprehensive Cancer Center at New York-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused ... http://www.mesotheliomacenter.org/mesothelioma-news/2008/06/26/new-clinical-trial-for-patients-with-asbestos-associated-lung-cancer-investigational-therapy-may-help-avoid-lung-removal-surgery-for-patients-with-pleural-mesothelioma/ With a latency period of 10-50 years, and with millions of Americans at risk for mesothelioma, an asbestos-generated cancer, the ravages of this life ending disease continue to disrupt families and lives. The Meso Foundation is hosting a press conference with leadership, members of Congress and three guest speakers who ... http://www.mesotheliomacenter.org/mesothelioma-news/2008/06/24/faces-of-mesothelioma-meso-foundation-press-conference-with-families-and-patients/ The New York State Department of Labor has issued a "Suspension of Asbestos Project" notice to Gordon Smith Contracting, due to numerous egregious violations of Code Rule 56, which governs asbestos removal. The company is in the second year of an ongoing project at the former Genesee Hospital. That site ... http://www.mesotheliomacenter.org/mesothelioma-news/2008/06/24/new-york-state-labor-department-suspends-rochester-asbestos-project/ Kansas City, KS - EPA Region 7 personnel will monitor air samples for asbestos and particulate matter in the continuing cleanup from a massive EF-5 tornado that killed seven people and injured at least 67 others in Parkersburg, Iowa, on May 25. EPA on-scene coordinators will oversee the air monitoring, which ... http://www.mesotheliomacenter.org/mesothelioma-news/2008/06/11/epa-to-conduct-air-monitoring-for-asbestos-and-particulate-matter-following-parkersburg-tornado/ MolMed S.p.A. (Milan:MLM) announces that the European Commission has granted Orphan Drug designation for MolMed’s investigational new antitumour therapeutic drug ARENEGYR (NGR-hTNFa) in the treatment of malignant pleural mesothelioma (MPM). The Commission decision, dated June 3rd 2008, follows the positive opinion released on April 9 by the Committee for Orphan ... http://www.mesotheliomacenter.org/mesothelioma-news/2008/06/06/the-european-commission-grants-orphan-drug-designation-for-molmed%e2%80%99s-vascular-targeting-agent-arenegyr-in-the-treatment-of-mesothelioma/ Public health advocates, led by the Asbestos Disease Awareness Organization (ADAO) and The John McNamara Foundation, today announced the formation of the Committee to Ban Asbestos in America (CBAA). Asbestos kills more than 10,000 men, women and children every year. The National Center for Health Statistics (NCHS) of the Centers ... http://www.mesotheliomacenter.org/mesothelioma-news/2008/06/04/public-heath-advocates-form-committee-to-ban-asbestos-in-america-committee-calls-on-the-us-congress-and-the-president-to-swiftly-ban-asbestos/ At the 44th ASCO (American Society of Clinical Oncology) Annual Meeting, MolMed S.p.A. (Milan:MLM) will present key preliminary results of two ongoing Phase II clinical trials with ARENEGYR (NGR-hTNF?) in chemo-pretreated patients with malignant pleural mesothelioma (MPM), and in heavily pre-treated patients with advanced colorectal cancer (CRC). Presented during two ... http://www.mesotheliomacenter.org/mesothelioma-news/2008/05/29/arenegyr-key-preliminary-results-of-phase-ii-trials-in-mesothelioma-and-colorectal-cancer-presented-at-asco/ Alfacell Corp. late Wednesday said results from its Phase IIIB clinical trial for Onconase, which was being studied as a potential treatment for unresectable malignant mesothelioma, didn't meet the trial's primary endpoint. The Somerset, N.J.-based biopharmaceutical company said a statistically significant improvement in survival was seen in the treatment of UMM ... http://www.mesotheliomacenter.org/mesothelioma-news/2008/05/29/alfacell-malignant-mesothelioma-treatment-trial-fails-to-meet-primary-endpoint/ Congresswoman Lois Capps (D-CA) and the staff of the House Energy and Commerce Committee organized a briefing for key staff members of the House, on the critical need for legislation to ban asbestos. Date: Monday, May 19th at 2 PM Location: Rayburn ... http://www.mesotheliomacenter.org/mesothelioma-news/2008/05/17/congresswoman-lois-capps-d-ca-highlights-need-for-asbestos-ban/ <p><strong>MicroRNAs as Potential Biomarkers -- for Lung Cancer Diagnosis and Identification of Tumor Origin in Patients With Cancer of Unknown Primary (CUP) MicroRNAs Objectively Identify Cancer Types With High Sensitivity and Specificity and Could Revolutionize Diagnosis and Treatment of Cancer</strong></p> <p><strong>Jersey City, NJ </strong> - Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader ... http://www.mesotheliomacenter.org/mesothelioma-news/2008/05/16/rosetta-genomics-to-present-multiple-posters-at-the-44th-annual-meeting-of-the-american-society-of-clinical-oncology-asco/